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Juvenile idiopathic arthritis: Diagnosis and differential 
diagnosis
Juvenile idiopathic arthritis (JIA) is comprised of a heterogeneous 
group of several disease subtypes that are characterized by the onset 
of arthritis before the age of 16 years and has symptoms lasting at 
least 6 weeks. The previous classification of JIA included seven 
different categories, whereas its current classification was compiled 
by the International League of the Association for Rheumatology, and 
replaced the previous terms of “juvenile chronic arthritis” and “juvenile 
rheumatoid arthritis,” which were used in Europe or North America, 
respectively, with the single nomenclature of JIA. As mentioned 
above, JIA is defined as arthritis of unknown etiology that manifests 
itself before the age of 16 years and persists for at least 6 weeks, while 
excluding other known conditions. The clinical symptoms of JIA can 
be quite variable. Several symptoms that are characteristic of arthritis 
are not necessarily diagnostic of JIA and may have multiple etiologies 
that can be differentiated with careful examination of patient history. 
The disease may develop over days or sometimes weeks, thereby 
making the diagnosis difficult at the time of presentation. To make a 
clinical diagnosis of JIA, the first step is to exclude arthritis with known 
etiologies. Of note, late treatment due to excessive delay of diagnosis 
can cause severe damage to joints and other organs and impair 
skeletal maturation. Therefore, early detection of JIA is critical to ensure 
prompt treatment and to prevent long-term complications including 
the likelihood of disability in childhood.
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in children has been described since the 1800s. George Frederick 
Still, an English pediatrician, described 22 children from Hospital 
for Sick Children, Great Ormond Street that had chronic arthritis1). 
It is still believed that 12 of these children had distinctive features 
of rheumatoid arthritis. Since this report, many additional children 
have been described with rheumatoid arthritis, and it has become 
Introduction
Juvenile idiopathic arthritis (JIA) is comprised of a heterogeneous 
group of several disease subtypes that are characterized by the 
onset of arthritis prior to the age of 16 years with symptoms that 
persist for more than 6 weeks. The occurrence of chronic arthritis 
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obvious that the disease we now call JIA or juvenile rheumatoid 
arthritis (JRA) is a particularly unpredictable and heterogeneous 
disease group. The previous classification of JIA described 7 
categories of the disease2), and the currently used classification 
was compiled by the International League of Associations for 
Rheumatology (ILAR). According to the updated ILAR system, 
the previous terms of  “juvenile chronic arthritis (JCA)” and “JRA,” 
which are used in Europe or North America, respectively, are 
replaced by the collective term JIA. Moreover, as mentioned above, 
this system defines JIA as arthritis of unknown etiology beginning 
before the age of 16 years and persisting for at least 6 weeks, while 
excluding other known conditions. As a consequence of the 
definition, JIA is not diagnosed before 6 weeks of onset, and final 
classification into one of its 7 subgroups is typically performed after 
6 months2). 
Classification
The classification of JIA provides an important framework 
for its research, as well as for assisting with identification of 
appropriate treatment and prediction of natural disease history. 
The aim of the ILAR classification system of JIA is to explain 
relatively homogeneous, mutually exclusive categories of idiopathic 
childhood arthritis based on predominant clinical laboratory 
Table 1. International League of Associations for Rheumatology (ILAR) Classification of Juvenile Idiopathic Arthritis (JIA)2)
Category Diagnostic criteria
Systemic arthritis Fever of at least 2 weeks’ duration (daily for at least 3 days) and arthritis in ≥1 joint, plus one or more of the following:
Erythematous rash
Generalized lymph node enlargement
Hepatomegaly and/or splenomegaly
Serositis
Exclusions: a, b, c, d
Oligoarthritis Arthritis affecting ≤4 joints during the first 6 months of disease
There are 2 subcategories:
Persistent: affecting nor more than 4 joints throughout the disease course
Extended: affecting more than 4 joints after the first 6 months of disease
Exclusions: a, b, c, d, e
Polyarthritis, RF(-) Arthritis affecting ≥5 joints during the first 6 months of disease
Test for RF is negative.
Exclusions: a, b, c, d, e
Polyarthritis, RF(+) Arthritis affecting ≥5 joints during the first 6 months of disease
2 or more test for RF at least 3 month apart during the first 6 months of disease are positive.
Exclusions: a, b, c, e
Psoriatic arthritis Arthritis and psoriasis, or arthritis and at least 2 of the following:
Dactylitis
Nail pitting or onycholysis
Psoriasis in a first-degree relative
Exclusions: b, c, d, e
Enthesitis related arthritis Arthritis and enthesitis, or arthritis or enthesitis with at least 2 of following:
The presence of or a history of sacroiliac joint tenderness and/or inflammatory lumbosacral pain
The presence of HLA-B27 antigen
Onset of arthritis in a male over 6 years of age
Acute (symptomatic) anterior uveitis
History of ankylosing spondylitis, enthesitis related arthritis, sacroiliitis with inflammatory bowel disease, Reiter’s syndrome, or 
acute anterior uveitis in a first-degree relative
Exclusions: a, d, e
Unclassified arthritis Arthritis that fulfills criteria in no category or in 2 or more of the above categories
One of the major aims of the ILAR classification is the mutual exclusivity of the subtypes. Therefore, the following list of possible exclusion for each category 
was defined:
a) Psoriasis or a history of psoriasis in the patient or first-degree relative.
b) Arthritis in an HLA-B27-positive male beginning after the sixth birthday.
c) Ankylosing spondylitis, enthesitis-related arhtiris, sacroiliitis with inflammatory bowel disease or acute anterior uveitis or a history of one of these disorders in a 
first-degree relative.
d) The presence of IgM rheumatoid factor and at least two occasions at least 3 months a part.
e) The presence of systemic JIA in the patient
RF, Rheumatoid factor
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features2). The current categories of JIA are shown in Table 12). 
1. Clinical diagnosis and differential diagnosis
The clinical symptoms of JIA can be variable. Several symptoms 
that indicate arthritis are not necessarily diagnostic of JIA, and 
may have multiple etiologies that can be differentiated with careful 
examination of patient history3). Polyarticular joint disease has a 
multi-factorial etiology, and may present as a viral illness or can 
be the beginning of a chronic disease. Moreover, its underlying 
etiological process can be infectious or post-infectious with a 
rheumatological disease or a manifestation of systemic disease. 
This disease may evolve over days or sometimes weeks, thereby 
making the diagnosis difficult at the time of presentation4). Thus, 
to accurately diagnose JIA, the first step is to exclude arthritis with 
known etiologies4) (Table 2).
In a child with acute-onset monoarthritis, the differential 
diagnosis must include septic arthritis, trauma, and hematologic 
diseases5). A painful joint effusion of short duration may be 
caused by trauma. It has been suggested that JIA may be the 
most common cause of chronic oligoarthritis. In a child with 
oligoarticular JIA, the affected joint is swollen and often warm, but 
is not typically very painful, tender, or red5). Moreover, if a joint is 
extremely painful and erythematous, or if the child is febrile, septic 
arthritis is more likely the correct diagnosis6). Such patients should 
undergo a test of prompt joint aspiration to exclude septic arthritis 
and osteomyelitis. The onset of polyarthritis in a preadolescent or 
adolescent girl potentially suggests the diagnosis of systemic lupus 
erythemtosus (SLE). The arthritis of SLE may follow that of JIA, 
but without undertaking serologic studies, its correct diagnosis may 
be difficult to make until the detection of the more characteristic 
clinical symptoms of SLE. 
The differential diagnosis of a child suspected of having systemic 
JIA is often difficult, especially at the onset or early in the course 
of the disease, when the child may have a high spiking fever with 
evidence of systemic inflammation but no arthritis or other specific 
signs that allow for a definitive diagnosis7). Children with systemic 
JIA may first be thought to have an acute infectious disease or 
septicemia. However, the presence of arthritis and/or a rheumatoid 
rash helps to establish an accurate diagnosis of systemic JIA. In 
contrast, laboratory tests may be of little value in diagnosing 
systemic JIA. Fever in children with infectious diseases is of the 
septic type; this type of fever is clinically more confusing and 
typically does not repetitively return to the baseline each day, as 
does the fever associated with JIA. That is, the diagnostic symptom 
of systemic JIA is a high spiking fever8), which may occur at any 
time of the day but is commonly present in the late afternoon to 
evening in conjunction with rash. In contrast, the temperature of 
an individual affected by JIA may be below normal in the morning. 
Moreover, JIA-associated fever can frequently accompany chills. 
Children commonly appear unwell while febrile, but surprisingly 
well during the rest of the day.
In our experience of assessing patients suspected of having 
JIA from 1990 to 2000, 51 cases were excluded to other diag-
noses, which included arthritis related to infection (61%), ma-
lig nancy (6%), other rheumatological disorders (26%), and 
immunodeficiency syndrome (4%)9). 
2. Laboratory examination
As briefly mentioned above, the diagnosis of JIA is essentially 
a clinical one. No laboratory test or combination of studies can 
Table 2. Differential diagnosis of Juvenile Idiopathic Arthritis in Children
Monoarticular arthritis Polyarticular arthritis Systemic onset
Acute onset
Early rheumatic disease
Oligoarticular JIA
Seronegative spondyloarthropathy
Arthritis related to infection
Septic arthritis
Reactive arthritis
Malignancy
Leukemia
Neuroblastoma
Hemophilia
Trauma
Chronic 
Oligoarticular JIA
Juvenile ankylosing spondylitis
Juvenile psoriatic arthritis
Villonodular synovitis
Sarcoidosis
Seronegative spondyloarthropathy
Juvenile psoriatic arthritis
Arthritides of inflammatory bowel disease
Systemic lupus erythematosus
Polyarthritis related to infection
Lyme disease
Reactive arthritis
Other
Sarcoidosis
Familial hypertrophic synovitis
Mucopolysaccharidoses
Infection
Inflammatory bowel disease
Connective tissue diseases
Systemic lupus erythematosus
Juvenile dermatomyositis
Vasculitis
Castleman’s disease
Familial Mediterranean fever
Hyper IgD syndrome
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confirm the diagnosis of JIA. However, the laboratory studies can 
be used to provide evidence of inflammation, support the clinical 
diagnosis of JIA, monitor toxicity of therapy, and better understand 
the pathogenesis of the disease. 
Hematologic abnormalities generally reflect the extent of the 
inflammatory disease. Useful laboratory investigations include 
count of blood cells (CBC) and inf lammatory markers like 
erythrocyte sedimentation rate (ESR) and C-reactive protein 
(CRP). However, the levels of ESR and CRP in active JIA are 
variable. In general, ESR is a useful measure of active disease at 
onset and during follow-up visits with a child with JIA, es pecially 
in polyarticular or systemic onset. Also, ESR is occasionally helpful 
in monitoring therapeutic efficacy. A CBC may show anemia of 
chronic disease if there has been longstanding inflammation. JIA-
associated anemia is attributable to chronic disease (low serum 
iron, low total iron-binding capacity, adequate hemosiderin store), 
although iron deficiency may also play an important role. It has 
been established that plasma iron transport and the amount of 
iron available for erythropoiesis decreases in individuals with 
systemic disease. Leukocytosis is common in children with active 
disease, and their platelet count may rise dramatically in cases with 
severe systemic or polyarticular involvement5). The concentrations 
of the serum immunoglobulins, IgG, IgA, and IgM, were 
previously determined in 200 patients with juvenile rheumatoid 
arthritis, which showed abnormality in the distribution of these 
immunoglobulins in JIA10). The serum levels of immunoglobulins 
are reportedly correlated with the activity of the disease and the 
acute phase response10, 11).
In a study of the diagnostic utility of rheumatoid factor (RF) 
serology in children, RF tests were shown to likely be positive 
in children with both JIA and diseases other than JIA12). Thus, 
evaluation of RFs is not useful as a diagnostic tool for JIA. 
How ever, children with high titers of RFs likely represent a 
subgroup distinctive from the larger number of children with 
seronegative disease. A RF test should be performed in patients 
with polyarthritis, as its presence has prognostic significance13). 
The presence of anti-nuclear antibody (ANA) deliberates risk for 
the development of asymptomatic uveitis, particularly in those 
individuals with oligoarticular onset disease, although assessment 
of ANA should be performed in all JIA patients14, 15). Anti-cyclic 
citrullinated peptide (anti-CCP) antibodies are not routinely 
tested in JIA patients, but may indicate severe disease16). Human 
leukocytic antigen (HLA) B27 should be examined in children 
who present with symptoms of enthesitis-related arthritis and 
can indicate susceptibility to the development of axial arthritis. 
Furthermore, if there is concern that arthritis is part of an under-
lying connective tissue disease or vaculitis, then it may be useful 
to test dsDNA, extractable nuclear antigen (ENA), C3, C4, and 
immunoglobulin levels. Finally, as most of the rheumatological 
tests lack in desired specificity, results should always be interpreted 
in the context of a given patient4, 17, 18). 
Conventional radiographs are the most easily available, quick, 
and inexpensive method of evaluating a joint. Ultrasonography is 
often the best way of identifying intra-articular fluid, particularly 
in joints such as the hip and shoulder, where fluid may be difficult 
to demonstrate clinically19). Increasing use of standard magnetic 
resonance (MR) imaging and the advances in more functional 
MR techniques over the past decade have improved the assessment 
of joint disease in JIA. Compared to ultrasonography or plain 
radiography, MR imaging is powerful in detecting inflammatory 
changes in the joint and cartilage damage. MR imaging is also 
able to precisely evaluate the later manifestations of JIA, including 
erosions, loss of joint space, cartilage damage, and ligamentous 
involvement19, 20) (Fig. 1). Moreover, bone scans using technetium 
-99m are also useful for detecting the early stage of inflammatory 
arthritis21) (Fig. 2). Unfortunately, no single modality meets every 
imaging requirement at this time, but methods for detecting JIA 
are dramatically improving22). 
Fig. 1. Magnetic resonance imaging of a patient with juvenile idiopathic arthritis shows 
synovial proliferation and effusion collection. Thick prominent enhancement along the synovial 
lining of the knee joint is shown.
Korean J Pediatr 2010;53(11):931-935 • DOI: 10.3345/kjp.2010.53.11.931    935
Conclusion
JIA is the most common rheumatic disease that affects children 
and is a significant cause of both short- and long-term disabilities. 
Specifically, JIA is defined as arthritis of unknown etiology and its 
diagnosis requires clinical exclusion of other known conditions. 
Excessive delay in instituting advanced treatment for JIA can 
result in irretrievable damage to joints and other organs and impair 
skeletal maturation. Thus, early detection of JIA is critical to ensure 
its prompt treatment and to prevent long-term complications, 
including the likelihood of disability during childhood. 
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Fig. 2. Whole body bone scan using technetium-99m shows increased bone 
uptake in the lesions of a patient with juvenile idiopathic arthritis.
